Venture Capital Turns to Mundane Industries AI and Dealmaking Reshape Accounting and Property Management US Payrolls Surpass Expectations But Report Signals Economic Concerns Former London Capital Finance Boss Jailed for Breaching Restraining Order by Selling Hot Tub and Luxury Items SpaceX and OpenAI MegaIPOs Could Signal Market Peak Analysts Suggest Retail Hiring Surge in April Contrasts with Consumer Caution Signals State Regulators vs Federal Oversight The Escalating Battle Over Prediction Markets PDS Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Edges Higher ZSTK Q4 2025 Earnings Massive EPS Miss as Losses Deepen WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates RILYZ Q1 2024 Earnings Negative EPS Reflects Challenging Quarter for BRC Group Holdings NATR Q1 2026 Earnings EPS Beats Estimates by Over 30 Amid Quiet Revenue Disclosure FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher BRC Inc BRCC Edges Lower as Stock Holds Near Key Support Level Spring Valley Acquisition Warrants Slide 6 as SPAC Market Sentiment Weakens American Public Education APEI Faces Slight Decline as Stock Tests Key Resistance Zone Eaton Vance Short Duration Diversified Income Fund EVG Slides Marginally as Market Weighs Income Strategies Lucas GC Limited LGCL Edges Higher Testing Key Resistance Levels Novartis Raises FullYear Sales and Profit Guidance on Strong Operational Performance Seaboard Corporation SEB Q1 2026 Earnings Strong EPS Performance Amid Mixed Market Signals Baldwin Insurance Group BWIN Advances 242 Nears Key 2044 Resistance Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results TNGX Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage AMWL Q1 2026 Earnings NarrowerThanExpected Loss Sends Shares Higher KT Q1 2026 Earnings EPS Miss Weighs on Shares Revenue Details Not Disclosed HWKN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher